Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Community-acquired pneumonia causes great mortality and morbidity and high costs
worldwide. Empirical selection of antibiotic treatment is the cornerstone of management of …

Purpose Severe community-acquired pneumonia (sCAP) is associated with high morbidity
and mortality, and whilst European and non-European guidelines are available for …

Severe pneumonia is associated with high mortality (short and long term), as well as
pulmonary and extrapulmonary complications. Appropriate diagnosis and early initiation of …

The rapid emergence and dissemination of antimicrobial-resistant microorganisms in ICUs
worldwide constitute a problem of crisis dimensions. The root causes of this problem are …

Severe community-acquired pneumonia is the most life-threatening form of community-
acquired pneumonia, characterised by intensive care unit admission and high morbidity and …

Background The correct management of immunocompromised patients with pneumonia is
debated. We evaluated the prevalence, risk factors, and characteristics of …

Abstract Background. The 2005 American Thoracic Society/Infectious Diseases Society of
America guidelines introduced a concept of healthcare-associated pneumonia (HCAP) to …

Rationale: Identification of patients with drug-resistant pathogens at initial diagnosis is
essential for treatment of pneumonia. Objectives: To elucidate clinical features of community …

Abstract Background. Prevalence of Staphylococcus aureus community-acquired
pneumonia (CAP) and its clinical features remain incompletely understood, complicating …